Outcomes and prognosis of patients with recurrent cervical cancer after radical hysterectomy

Gynecologic Oncology

Volumn 127, Issue 3, 2012, Pages 472-477

  Qiu, Jian Tai ^a,b   Abdullah, Nor Anita ^c   Chou, Hung Hsueh ^a   Lin, Cheng Tao ^a   Jung, Shih Ming ^b   Wang, Chun Chieh ^a   Chen, Min Yu ^a   Huang, Kuan Gen ^a   Chang, Ting Chang ^a   Lai, Chyong Huey ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c Hospital Sultanah Bahiyah   (Malaysia)

Author keywords

Cervical cancer; Prognostic factors; Recurrence; Salvage

Indexed keywords

CARBOPLATIN; CISPLATIN; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; IFOSFAMIDE; PACLITAXEL; TOPOTECAN;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PALLIATIVE THERAPY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIMODAL CHEMOTHERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PELVIS LYMPH NODE; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; RADIATION DOSE; RADICAL HYSTERECTOMY; RECURRENT CANCER; SALVAGE THERAPY; SQUAMOUS CELL CARCINOMA; TREATMENT FAILURE; TUMOR VOLUME; UTERINE CERVIX CANCER; VAGINA CANCER;

ADULT; AGED; FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 84868559734     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2012.08.008     Document Type: Article

References (18)

1. GLOBOCAN http://globocan.iarc.fr/ 2008 (access on April 14, 2012)
2. Bureau of Health Promotion Department of Health, Taiwan Cancer Registry Annual Report 2008 http://www.bhp.doh.gov.tw/BHPnet/Portal/StatisticsShow.aspx? No=200911300001
3. L. Elit, A.W. Fyles, M.C. Devries, T.K. Oliver, and M. Fung-Kee-Fung Follow-up for women after treatment for cervical cancer: a systematic review Gynecol Oncol 114 2009 528 535
4. C.H. Lai, C.J. Chang, H.J. Huang, S. Hsueh, A. Chao, and J.E. Yang Role of human papillomavirus genotype in prognosis of early-stage cervical cancer undergoing primary surgery J Clin Oncol 25 2007 3628 3634
5. C.H. Lai, S.G. Tang, T.C. Chang, C.J. Tseng, H.H. Chou, and K.G. Huang Implications of a failed prospective trial of adjuvant therapy after radical hysterectomy for stage Ib-IIa cervical carcinoma with pelvic node metastases Chang Gung Med J 21 1998 291 299
6. J.H. Hong, C.S. Tsai, C.H. Lai, T.C. Chang, C.C. Wang, and S.P. Lee Postoperative low-pelvic irradiation for stage I-IIA cervical cancer patients with risk factors other than pelvic lymph node metastasis Int J Radiat Oncol Biol Phys 53 2002 1284 1290
7. C.J. Wang, C.H. Lai, J.H. Hong, H.H. Chou, and K.G. Huang Recurrent cervical carcinoma after primary radical surgery Am J Obstet Gynecol 181 1999 518 524
8. G. Delgado, B.N. Bundy, W.C. Fowler Jr., F.B. Stehman, B. Sevin, and W.T. Creasman A prospective surgical pathological study of stage I squamous carcinoma of the cervix: a gynecologic oncology group study Gynecol Oncol 35 1989 314 320
9. W.D. Kang, C.H. Kim, M.K. Cho, J.W. Kim, H.Y. Cho, and Y.H. Kim HPV-18 is a poor prognostic factor, unlike the HPV viral load, in patients with stage IB-IIA cervical cancer undergoing radical hysterectomy Gynecol Oncol 121 2011 546 550
10. R.A. Burger, B.J. Monk, T. Kurosaki, H. Anton-Culver, S.A. Vasilev, and M.L. Berman Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer J Natl Cancer Inst 88 1996 1361 1368
11. H. Pilch, S. Gunzel, U. Schaffer, B. Tanner, P. Brockerhoff, and M. Maeurer The presence of HPV DNA in cervical cancer: correlation with clinico-pathologic parameters and prognostic significance: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University Int J Gynecol Cancer 11 2001 39 48
12. H.Y. Yhim, N.R. Lee, E.K. Song, J.Y. Kwak, S.T. Lee, and J.H. Kim The prognostic significance of tumor human papillomavirus status for patients with anal squamous cell carcinoma treated with combined chemoradiotherapy Int J Cancer 129 2011 1752 1760
13. J.P. Klussmann, J.J. Mooren, and M. Lehnen Genetic signatures of HPV-related and unrelated oropharygeal carcinoma and their prognostic implications Clin Cancer Res 15 2009 1779 1786
14. R. dos Reis, M. Frumovitz, M.R. Milam, E. Capp, C.C. Sun, and R.L. Coleman Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis Gynecol Oncol 107 2007 458 463
15. Y.Y. Lee, C.H. Choi, T.J. Kim, J.W. Lee, B.G. Kim, and J.H. Lee A comparison of pure adenocarcinoma and squamous cell carcinoma of the cervix after radical hysterectomy in stage IB-IIA Gynecol Oncol 120 2011 439 443
16. T. Nakanishi, H. Ishikawa, Y. Suzuki, T. Inoue, S. Nakamura, and K. Kuzuya A comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervix Gynecol Oncol 79 2000 289 293
17. K.C. Ho, C.C. Wang, J.T. Qiu, C.H. Lai, J.H. Hong, and A. Chao Identification of prognostic factors in patients with cervical cancer and supraclavicular lymph node recurrence Gynecol Oncol 123 2011 253 256
18. C.T. Lin, T.C. Yen, T.C. Chang, K.K. Ng, C.S. Tsai, and K.C. Ho Role of [18F]fluoro-2-deoxy-D-glucose positron emission tomography in re-recurrent cervical cancer Int J Gynecol Cancer 16 2006 1994 2003